REG - Futura Medical PLC - Block Listing Update <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

11/11/2014 08:32

RNS Number : 6583W
Futura Medical PLC
11 November 2014
For immediate release
11 November 2014
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in April 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans.
The table below provides further detail.
Name of company:
Futura Medical plc
Name of scheme:
Unapproved Share Option Scheme ("USOS")
EMI Share Option Scheme ("EMI")
Period of return:
From:  28 April 2014
To:   10 November 2014
Number and class of securities not issued under the scheme(s)
USOS:  1,786,435 ordinary shares of 0.2p
EMI:   1,828,306 ordinary shares of 0.2p
Total:  3,614,741
Number of securities issued under the scheme(s) during the period
USOS:  Nil
EMI:  Nil
Balance under the scheme(s) of securities not yet issued at the end of the period
USOS:  1,786,435
EMI:  1,828,306
Total: 3,614,741
Number and class of securities originally admitted and the date of admission
USOS:  814,424 on 25 May 2011 and
 1,193,959 on 8 October 2013
Total: 2,008,383 Total
EMI: 1,520,576 on 25 May 2011 and
 1,476,041 on 8 October 2013
Total: 2,996,617 Total
Total: 5,005,000
Name of contact:
Derek Martin, Chief Financial Officer
Telephone number of contact:
+44 (0) 1483 685 670
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0)1483 685 670
mail to:james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
N+1 Singer
Aubrey Powell 
Tel:+44 (0)20 7496 3000


For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles
Tel: +44 (0)20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
BLRGGGCAGUPCPUU